QA: SELLAS Life Sciences Group Inc. in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001390478_2023_SELLAS_Life_Sciences_Group_Inc.pdf

Logs

Graph

Absolute values for 0001390478, SELLAS Life Sciences Group Inc.

  xvar xval
0 AssetsCurrent 17,756,000
1 IntangibleAssetsNetIncludingGoodwill 1,914,000
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 1,273,000
4 LiabilitiesCurrent 15,515,000
5 LiabilitiesNoncurrent 573,000
6 remainder_Liabilities 4,000
7 CostOfGoodsAndServicesSold 100,000
8 SellingGeneralAndAdministrativeExpense 12,582,000
9 ResearchAndDevelopmentExpense 20,268,000
10 remainder_Expenses 10,000,000
11 remainder_Revenues 1,000,000
12 remainder_NetIncome 649,000
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 20,943,000
1 Liabilities 16,092,000
2 Expenses 42,950,000
3 Revenues 1,000,000
4 StockholdersEquity 4,851,000
5 NetIncome -41,301,000
6 ComprehensiveNetIncome -41,301,000
7 BaseVar 40,817,000
8 EconomicCapitalRatio -1.78

Edgar->Model Mapping

Feature Distribution

Change over Time